Racial and Ethnic Disparities in Non-Alcoholic Fatty Liver Disease: New Insights

Strategic Insights -

Researchers from the University of Lorraine, France, have shed light on the growing global health concern of non-alcoholic fatty liver disease (NAFLD), which affects approximately 32.4% of the worldwide population. NAFLD is linked to metabolic dysfunction and has been rising alongside global increases in obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome. Despite efforts to understand the disease, the exact reasons for the disparities in NAFLD among racial, ethnic, and minority groups remain elusive. A new study aims to explore the connections between NAFLD, ethnic disparities, gut microbiota composition, and epigenetic alterations, as well as potential therapeutic targets and biomarkers.

Key Takeaways:

  • NAFLD affects approximately 32.4% of the worldwide population, making it a significant global health concern.
  • NAFLD is linked to metabolic dysfunction and has been rising alongside global increases in obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome.
  • The exact reasons for the disparities in NAFLD among racial, ethnic, and minority groups remain elusive, with contributing factors including socioeconomic status, cultural influences, stress, genetic factors, and lifestyle choices.
  • Emerging evidence suggests that epigenetic mechanisms, particularly DNA methylation and histone modifications, as well as the composition and diversity of gut microbiota, may influence disease disparities.
  • The study aims to explore the connections between NAFLD, ethnic disparities, gut microbiota composition, and epigenetic alterations, as well as potential therapeutic targets and biomarkers.
  • The findings of this study are expected to enhance our understanding of disease susceptibilities in at-risk groups and provide new therapeutic options for NAFLD and its associated complications.
  • Mohamed Zaiou and Olivier Joubert from the University of Lorraine-led research team conducted the study, with additional authors participating in the research project.

Statistics:

  • 32.4% of the worldwide population is affected by NAFLD.
  • NAFLD is rising alongside global increases in obesity, type 2 diabetes mellitus (T2DM), and metabolic syndrome.
  • The study aims to explore the connections between NAFLD, ethnic disparities, gut microbiota composition, and epigenetic alterations in 15 different populations.

Sources:

  • Biomolecules journal - http://www.mdpi.com/journal/biomolecules
  • MDPI AG (publisher) - http://www.mdpi.com/
  • DOI: 10.3390/biom15050669 - https://doi.org.sdpl.idm.oclc.org/10.3390/biom15050669